Clinical Trial

Helping People Survive with Bladder Urothelial Carcinoma

Study Description

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

The investigators would like to compare the progression free survival, overall survival, quality of life, and safety outcomes of patients receiving versus not receiving a 2nd transurethral resection of bladder tumor.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Procedure - re-TURBT

2nd bladder biopsy within 4-6 weeks of initial biopsy

Drug - 6 weeks BCG instillation

standard 6 weeks of BCG induction

Additional Information

Official Study Title

A Pilot, Single-centre, Randomized, 5-year, Parallel-group, Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Clinical Trial ID

NCT03266900

ParticipAid ID

9av4Vd